Generic Drugs Market Research Reports & Industry Analysis
Prescription generic pharmaceuticals are the non-patented chemical and therapeutic equivalents of brand-name drugs. These low-cost alternatives must contain the same active chemical ingredient and rate of absorption as the branded product. Due to high demand an increase in the number of generic drug approvals, the global generic drugs market has expanded at a steady pace over the years, and new growth opportunities are anticipated in the future. Check out our research collection to learn more about this lucrative market.
New Generic Drugs Industry Research
- Find quality data on industries big and small, whether you are interested in a specific product, region, or country.
- Gain in-depth research on generic drug market segmentation, patents, clinical trials, funding, and regulatory framework.
- Discover valuable new market opportunities, pockets of growth, and strategies to sustain success.
A Trusted Name in Research
MarketResearch.com offers a wealth of resources to propel your success through data-driven decision-making. We are proud to serve top investment banks, management consulting firms, leading life science companies, and universities—with a track record spanning decades and an experienced team to support your research needs. Explore our generic drugs industry reports today and embrace the power of foresight in an evolving market.
Generics Drugs Industry Research & Market Reports
-
Generics Global Industry Almanac 2019-2028
... leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have ... Read More
-
Generics Top 5 Emerging Markets Industry Guide 2019-2028
... also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights These countries contributed $1,61,156.7 million to the global generics industry in 2023, with a ... Read More
-
Generics BRIC (Brazil, Russia, India, China) Industry Guide 2019-2028
... also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries ... Read More
-
Generics Global Industry Guide 2019-2028
... leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have ... Read More
-
Generics Global Group of Eight (G8) Industry Guide 2019-2028
... also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The G8 countries contributed $1,61,715.9 million in 2023 to the global generics industry, with ... Read More
-
Generics North America (NAFTA) Industry Guide 2019-2028
... descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North ... Read More
-
Generics in Australia
... players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now ... Read More
-
Generics in China
... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that ... Read More
-
Generics in Turkey
... players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now ... Read More
-
Generics in Europe
... key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both ... Read More
-
Global Generics
... key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both ... Read More
-
Generics in Mexico
... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that ... Read More
-
Generics in Scandinavia
... key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both ... Read More
-
Generics in Singapore
... key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both ... Read More
-
Generics in the United Kingdom
... descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by ... Read More
-
Generics in Asia-Pacific
... key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both ... Read More
-
Generics in Brazil
... players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now ... Read More
-
Generics in India
... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that ... Read More
-
Generics in Japan
... key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both ... Read More
-
Generics in South Africa
... players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now ... Read More
-
Generics in South Korea
... players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now ... Read More
-
Generics in Italy
... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that ... Read More
-
Generics in North America
... players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now ... Read More
-
Generics in Canada
... key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both ... Read More
-
Generics in Spain
... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that ... Read More
Research Assistance
